These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 33344225)
1. Development and Validation of Nomograms Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio for Hepatocellular Carcinoma Patients Reveal Novel Prognostic Value and the Ratio Is Negatively Correlated With P38MAPK Expression. Luo D; Li H; Hu J; Zhang M; Zhang S; Wu L; Han B Front Oncol; 2020; 10():548744. PubMed ID: 33344225 [TBL] [Abstract][Full Text] [Related]
2. Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion. Ma M; Xie K; Jin T; Xu F BMC Cancer; 2024 May; 24(1):617. PubMed ID: 38773511 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of a prognostic model based on the albumin-to-fibrinogen ratio (AFR) and gamma-glutamyl transpeptidase-to-platelet ratio (GPR) in hepatocellular carcinoma patients. Zhang J; Wang T; Xu L; Wang P; Zhang M; Xu M Clin Chim Acta; 2020 Dec; 511():107-116. PubMed ID: 33035501 [TBL] [Abstract][Full Text] [Related]
4. Prognostic nomogram based on the gamma-glutamyl transpeptidase-to-platelet ratio for patients with compensated cirrhotic hepatocellular carcinoma after local ablation. Qiao W; Li J; Wang P; Zhang Y; Jin R; Li J Front Oncol; 2024; 14():1406764. PubMed ID: 39055565 [TBL] [Abstract][Full Text] [Related]
5. Novel Nomogram Based on Inflammatory Markers for the Preoperative Prediction of Microvascular Invasion in Solitary Primary Hepatocellular Carcinoma. Gu Y; Zheng F; Zhang Y; Qiao S Cancer Manag Res; 2022; 14():895-907. PubMed ID: 35256861 [TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma. Wang X; Mao M; He Z; Zhang L; Li H; Lin J; He Y; Dai S; Hu W; Liu W Int J Biol Sci; 2019; 15(1):221-228. PubMed ID: 30662361 [TBL] [Abstract][Full Text] [Related]
7. Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy. Wu JL; Luo JY; Jiang ZB; Huang SB; Chen GR; Ran HY; Liang QY; Huang MS; Lai LS; Chen JW World J Gastroenterol; 2023 May; 29(20):3168-3184. PubMed ID: 37346152 [TBL] [Abstract][Full Text] [Related]
8. γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma. Sun LJ; Guan A; Xu WY; Liu MX; Yin HH; Jin B; Xu G; Xie FH; Xu HF; Du SD; Xu YY; Zhao HT; Lu X; Sang XT; Yang HY; Mao YL World J Gastrointest Oncol; 2020 Sep; 12(9):1014-1030. PubMed ID: 33005295 [TBL] [Abstract][Full Text] [Related]
9. Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection. Zeng J; Zeng J; Wu Q; Lin K; Zeng J; Guo P; Zhou W; Liu J Ann Transl Med; 2020 Sep; 8(17):1061. PubMed ID: 33145280 [TBL] [Abstract][Full Text] [Related]
10. Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy. Ma C; Cao Y; Zhang G; Qiu J; Zhou Y; Wang P; Wang S; Yan D; Ma D; Jiang C; Wang Z J Hepatocell Carcinoma; 2023; 10():217-230. PubMed ID: 36798739 [TBL] [Abstract][Full Text] [Related]
11. Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection. Ren L; Chen D; Xu W; Xu T; Wei R; Suo L; Huang Y; Chen H; Liao W BMC Cancer; 2021 Jul; 21(1):817. PubMed ID: 34266388 [TBL] [Abstract][Full Text] [Related]
12. Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy. Wang Y; Sun K; Shen J; Li B; Kuang M; Cao Q; Peng S Cancer Res Treat; 2019 Oct; 51(4):1464-1478. PubMed ID: 30913869 [TBL] [Abstract][Full Text] [Related]
13. A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma. Yang D; Wu H; Nong W; Zheng M; Li A; Wang Y; Li M; Chen Q; Yuan S; Yu J; Liao W Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101509. PubMed ID: 33744828 [TBL] [Abstract][Full Text] [Related]
14. A Novel Nomogram Based on Hepatic and Coagulation Function for Evaluating Outcomes of Intrahepatic Cholangiocarcinoma After Curative Hepatectomy: A Multi-Center Study of 653 Patients. Cai Y; Zhang B; Li J; Li H; Liu H; Xie K; Du C; Wu H Front Oncol; 2021; 11():711061. PubMed ID: 34322394 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of combined preoperative gamma-glutamyl transpeptidase to platelet ratio and fibrinogen in patients with HBV-related hepatocellular carcinoma after hepatectomy. Dai T; Deng M; Ye L; Liu R; Lin G; Chen X; Li H; Liu W; Yang Y; Chen G; Wang G Am J Transl Res; 2020; 12(6):2984-2997. PubMed ID: 32655824 [TBL] [Abstract][Full Text] [Related]
16. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio. Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683 [TBL] [Abstract][Full Text] [Related]
17. The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis. Liu K; Huang Z; Yang S; Lin L; Zheng S; Zhang X; Xue Y; Xie W J Hepatocell Carcinoma; 2022; 9():1057-1063. PubMed ID: 36250136 [TBL] [Abstract][Full Text] [Related]
18. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma. Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W Front Oncol; 2022; 12():946531. PubMed ID: 35936698 [TBL] [Abstract][Full Text] [Related]
19. Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection. Zhang CH; Ni XC; Chen BY; Qiu SJ; Zhu YM; Luo M J Cancer; 2019; 10(20):4836-4845. PubMed ID: 31598154 [No Abstract] [Full Text] [Related]
20. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study. Zang Y; Long P; Wang M; Huang S; Chen C Future Oncol; 2021 Dec; 17(36):5053-5066. PubMed ID: 34676798 [No Abstract] [Full Text] [Related] [Next] [New Search]